PAHC
PHIBRO ANIMAL HEALTH CORP
Key Financials
Operating Income
$194.4M
↑ 76.0%
Gross Profit
$512.5M
↑ 28.1%
Net Income
$99.7M
↑ 106.6%
Revenue
$1.5B
↑ 17.1%
EPS (Diluted)
$2.43
↑ 104.2%
Total Assets
$1.5B
↑ 10.3%
Total Liabilities
$1.1B
↑ 3.8%
Shareholders' Equity
$385.5M
↑ 34.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| ARS | 9/18/2026 | View on SEC |
| DEFA14A | 9/18/2026 | View on SEC |
| DEF 14A | 9/18/2026 | View on SEC |
| 4/A | 9/17/2026 | View on SEC |
| 4/A | 9/17/2026 | View on SEC |
| 144 | 9/16/2026 | View on SEC |
| 8-K | 8/26/2026 | View on SEC |
| 10-K | 8/26/2026 | View on SEC |
| 4 | 8/10/2026 | View on SEC |
| 4 | 8/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PAHC |
| Company Name | PHIBRO ANIMAL HEALTH CORP |
| CIK | 1069899 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | 201-329-7300 |